Publications by authors named "Fabrizio Febo"

Claim this Profile
O
Oral Semaglutide in Routine Clinical Practice: Characteristics of People with Type 2 Diabetes Started on the Drug and Changes in Their Clinical Parameters after 24 Weeks of Treatment.
Maria Pompea Antonia Baldassarre, Giulia Di Dalmazi, Sara Coluzzi, Federica Carrieri, Fabrizio Febo

J Clin Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exenatide Once Weekly: Effectiveness, Tolerability, and Discontinuation Predictors in a Real-world Setting.
Giulia Di Dalmazi, Sara Coluzzi, Maria P A Baldassarre, Sofia Elena Sorbo, Stefania Dell'Aquila, Fabrizio Febo

Clin Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative safety review between GLP-1 receptor agonists and SGLT2 inhibitors for diabetes treatment.
Agostino Consoli, Gloria Formoso, Maria Pompea Antonia Baldassarre, Fabrizio Febo

Expert Opin Drug Saf· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Type 2 diabetes treatment and cardiovascular risk: what can we learn from trials?].
Agostino Consoli, Fabrizio Febo

G Ital Cardiol (Rome)· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis